Aurigon Announces Corporate Reorganization, Financial Restructure in Preparation for Global Expansion

BUDAPEST, Hungary – November 27, 2023 – Aurigon Group, a leading service provider in the pharmaceutical and healthcare industry, is pleased to announce the completion of a corporate reorganization, branding the group Aurigon Labs and financial restructuring, significantly strengthening its balance sheets to position the group of further growth.

With the incorporation of Aurigon Labs and its strong balance sheet, the group is now strategically positioned to leverage its significant talents and deliver innovative solutions to its global client base. Aurigon Labs firmly believes that Hungary offers a highly conducive environment for its research services. Hungary has significant talent and expertise in the fields of biology, preclinical services, and drug development. In addition, Budapest’s convenient location in Central Europe, up to three-hour flight from most European cities, make the country an attractive destination for pharmaceutical research initiatives.

“Our shareholders are confident in the positioning of Aurigon and the tremendous potential Hungary holds for the preclinical trial segment,” commented CEO Istvan Gacsalyi. “The dedication and hard work demonstrated by our team have paved the way for our success, and we are excited about the growth opportunities that lie ahead.”

Aurigon Labs’ major client base is primarily focused in the DACH region (Germany, Austria, and Switzerland) and includes renowned pharmaceutical players, small-medium size biotech companies, and research institutions. The Company’s recent expansion efforts have also resulted in the acquisition of new clients from the United Kingdom to the United States.

About Aurigon Labs:
Aurigon Labs is a leading pharmaceutical and healthcare company that specializes in preclinical trial development, research, and analysis. With a focus on innovation and excellence, the company is committed to advancing the healthcare industry through cutting-edge technologies and solutions.

For inquiries, please contact:
Istvan Gacsalyi
Aurigon Labs